OCUP – ocuphire pharma, inc. (US:NASDAQ)
Stock Stats
News
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting [Yahoo! Finance]
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery [Yahoo! Finance]
First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) for the Treatment of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Form ARS Ocuphire Pharma, Inc. For: Dec 31
Form DEFA14A Ocuphire Pharma, Inc.
Form DEF 14A Ocuphire Pharma, Inc. For: Jun 11
Form PRE 14A Ocuphire Pharma, Inc. For: Jun 11
Form 8-K Ocuphire Pharma, Inc. For: Apr 11
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.